Amgen And Provention Bio Announce Co-Development Collaboration In Celiac Disease

Author's Avatar
Nov 05, 2018
Article's Main Image

Provention to Lead Phase 2b Stage of Development for Anti-IL-15 Antibody AMG 714

Amgen Will Invest $20 Million in Provention Equity

Amgen Will be Responsible for Clinical Trial Supply and Manufacturing

PR Newswire